| Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Q Fernandes, VP Inchakalody, M Merhi, S Mestiri, N Taib, ... Annals of medicine 54 (1), 524-540, 2022 | 370 | 2022 |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances KM Maalej, M Merhi, VP Inchakalody, S Mestiri, M Alam, C Maccalli, ... Molecular Cancer 22 (1), 20, 2023 | 118 | 2023 |
| Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy A Raza, M Merhi, VP Inchakalody, R Krishnankutty, A Relecom, S Uddin, ... Journal of Translational Medicine 18, 1-11, 2020 | 86 | 2020 |
| Role of Epstein–Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target Q Fernandes, M Merhi, A Raza, VP Inchakalody, N Abdelouahab, ... Frontiers in oncology 8, 257, 2018 | 58 | 2018 |
| Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer A Raza, AQ Khan, VP Inchakalody, S Mestiri, ZSKM Yoosuf, T Bedhiafi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 99, 2022 | 55 | 2022 |
| Molecular pharming: future targets and aspirations M Paul, C Dolleweerd, PMW Drake, R Reljic, H Thangaraj, T Barbi, ... Human Vaccines 7 (3), 375-382, 2011 | 48 | 2011 |
| Contributions of the international plant science community to the fight against human infectious diseases–part 1: epidemic and pandemic diseases M Lobato Gomez, X Huang, D Alvarez, W He, C Baysal, C Zhu, ... Plant biotechnology journal 19 (10), 1901-1920, 2021 | 47 | 2021 |
| The potential role of vitamin C in empowering cancer immunotherapy T Bedhiafi, VP Inchakalody, Q Fernandes, S Mestiri, N Billa, S Uddin, ... Biomedicine & Pharmacotherapy 146, 112553, 2022 | 40 | 2022 |
| Contributions of the international plant science community to the fight against infectious diseases in humans—part 2: Affordable drugs in edible plants for endemic and re … W He, C Baysal, M Lobato Gomez, X Huang, D Alvarez, C Zhu, ... Plant biotechnology journal 19 (10), 1921-1936, 2021 | 31 | 2021 |
| Heterologous expression of Lolium perenne antifreeze protein confers chilling tolerance in tomato S Balamurugan, JS Ann, IP Varghese, SB Murugan, MC Harish, ... Journal of integrative agriculture 17 (5), 1128-1136, 2018 | 26 | 2018 |
| Anti-cancer effects of Tranilast: an update S Osman, A Raza, L Al-Zaidan, VP Inchakalody, M Merhi, KS Prabhu, ... Biomedicine & Pharmacotherapy 141, 111844, 2021 | 23 | 2021 |
| Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity A Relecom, M Merhi, V Inchakalody, S Uddin, D Rinchai, D Bedognetti, ... Journal of Experimental & Clinical Cancer Research 40, 1-19, 2021 | 22 | 2021 |
| Squamous cell carcinomas of the head and neck cancer response to programmed cell death protein-1 targeting and differential expression of immunological markers: a case report M Merhi, A Raza, VP Inchakalody, AJJ Nashwan, N Allahverdi, ... Frontiers in immunology 9, 1769, 2018 | 21 | 2018 |
| The role of PAK4 in the immune system and its potential implication in cancer immunotherapy A Naїja, M Merhi, V Inchakalody, Q Fernandes, S Mestiri, KS Prabhu, ... Cellular Immunology 367, 104408, 2021 | 20 | 2021 |
| Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma MO Mohsen, DE Speiser, J Michaux, HS Pak, BJ Stevenson, M Vogel, ... Journal for immunotherapy of cancer 10 (1), 2022 | 16 | 2022 |
| Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer … S Akbar, A Raza, R Mohsin, A Kanbour, S Qadri, A Parray, AR Zar Gul, ... Frontiers in Immunology 13, 1097117, 2023 | 15 | 2023 |
| Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy … M Merhi, A Raza, VP Inchakalody, KS Siveen, D Kumar, F Sahir, S Mestiri, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 13 | 2020 |
| Neutralization of MERS coronavirus through a scalable nanoparticle vaccine MO Mohsen, D Rothen, I Balke, B Martina, V Zeltina, V Inchakalody, ... npj Vaccines 6 (1), 107, 2021 | 12 | 2021 |
| The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update M Merhi, F Ahmad, N Taib, V Inchakalody, S Uddin, A Shablak, ... Seminars in Cancer Biology 89, 1-17, 2023 | 11 | 2023 |
| Potential of plant biologics to tackle the epidemic like situations-case studies involving viral and bacterial candidates G Iyappan, BM Shanmugaraj, V Inchakalody, JKC Ma, S Ramalingam International Journal of Infectious Diseases 73, 363, 2018 | 11 | 2018 |
